Organization · Corporate Venture Capital
Eisai Innovation Inc
Eisai Innovation Inc. is the corporate venture capital arm of Eisai Co., Ltd., focusing on investments in innovative biotech and digital health companies. Established in 2019, it operates globally with a strategic emphasis on neurology and oncology.
Overview
What Eisai Innovation Inc does
What Eisai Innovation Inc is
Eisai Innovation Inc. is the corporate venture capital arm of Eisai Co., Ltd., focusing on investments in innovative biotech and digital health companies. Established in 2019, it operates globally with a strategic emphasis on neurology and oncology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Eisai Innovation Inc elsewhere
Open the official website or a supported primary organization account.
Capability profile
Eisai Innovation Inc as a funder
Investment thesis
Eisai Innovation Inc. aims to create a world free from the fear and pain of disease by identifying synergies between the scientific community and the Eisai network, focusing on investments in neurology and oncology, including digital solutions and diagnostics.
Focus narrative
Eisai Innovation Inc. invests primarily in the fields of neurology and oncology, including their digital solutions and diagnostics. The organization targets investments of approximately $5 million each and operates globally, with a focus on regions such as the US, Europe, Japan, China, and emerging markets including Africa.
Value beyond capital
Eisai Innovation Inc. adds value to its portfolio companies by leveraging the extensive Eisai network, providing strategic guidance, and facilitating collaborations within the healthcare ecosystem to enhance innovation and market reach.
Terms and economics
- Typical check
- $5,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Sectors
- Digital Health · Diagnostics · AI
- Regions
- Global · North America · Europe · Asia · Africa
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Arteryex Inc.
Portfolio context
Eisai Innovation Inc. has invested in over 30 companies since its inception, with notable portfolio companies including Arteryex Inc., which became a subsidiary of Eisai as of March 31, 2022.
Common questions
What to know about Eisai Innovation Inc
Upseed classifies Eisai Innovation Inc under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.